The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease
Open accessAbstract
Frontotemporal lobar degeneration with TAR DNA-binding protein 43 inclusions (FTLD-TDP) is the most common pathology associated with frontotemporal dementia (FTD). Repeat expansions in chromosome 9 open reading frame 72 (C9ORF72) and mutations in progranulin (GRN) are the major known genetic causes of FTLD-TDP; however, the genetic etiology in the majority of FTLD-TDP remains unexplained. In this study, we performed whole-genome sequencing in 104 pathologically confirmed FTLD-TDP patients from the Mayo Clinic brain bank negative for C9ORF72 and GRN mutations and report on the contribution of rare single nucleotide and copy number variants in 21 known neurodegenerative disease genes. Interestingly, we identified 5 patients (4.8 %) with variants in optineurin (OPTN) and TANK-binding kinase 1 (TBK1) that are predicted to be highly pathogenic, including two double mutants. Case A was a compound heterozygote for mutations in OPTN, carrying the p.Q235* nonsense and p.A481V missense mutation in trans, while case B carried a deletion of OPTN exons 13-15 (p.Gly538Glufs*27) and a loss-of-function mutation (p.Arg117*) in TBK1. Cases C-E carried heterozygous missense mutations in TBK1, including the p.Glu696Lys mutation which was previously reported in two amyotrophic lateral sclerosis (ALS) patients and is located in the OPTN binding domain. Quantitative mRNA expression and protein analysis in cerebellar tissue showed a striking reduction of OPTN and/or TBK1 expression in 4 out of 5 patients supporting pathogenicity in these specific patients and suggesting a loss-of-function disease mechanism. Importantly, neuropathologic examination showed FTLD-TDP type A in the absence of motor neuron disease in 3 pathogenic mutation carriers. In conclusion, we highlight TBK1 as an important cause of pure FTLD-TDP, identify the first OPTN mutations in FTLD-TDP, and suggest a potential oligogenic basis for at least a subset of FTLD-TDP patients. Our data further add to the growing body of evidence linking ALS and FTD and suggest a key role for the OPTN/TBK1 pathway in these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Supporting the link between ALS and FTD, TBK1 mutations have also been identified in FTD patients, and in fact occur more frequently in patients with combined ALS-FTD than in those with ALS alone [207–209].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [209]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 13×
“The most striking evidence, however, came from the identification of repeat expansions in C9ORF72 as a common cause of FTD, ALS and mixed FTD-ALS patients, which firmly established a genetic link between these disorders [14, 45].”
BackgroundInfluentialSelf-citationA Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citationArai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Vance, C. A., Rogelj, B., Hortobágyi, T., Vos, K. J. D., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B. N., Ruddy, D., Wright, P. D., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,625
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
Kwiatkowski, T. J., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J. M., Kasarskis, E. J., Munsat, T. L., et al. (2009) · Science · doi:10.1126/science.1166066 · Cited by 2,624
Cited by
Sorted by citations
Brown, R. H., & Al‐Chalabi, A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1603471 · Cited by 2,580
Proteasomal and Autophagic Degradation Systems
Đikić, I. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044908 · Cited by 1,217
Richter, B., Sliter, D. A., Herhaus, L., Stolz, A., Wang, C., Beli, P., Zaffagnini, G., Wild, P., Martens, S., Wagner, S. A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523926113 · Cited by 755
Autophagy: The spotlight for cellular stress responses
Ravanan, P., Florance, I., & Talwar, P. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.08.029 · Cited by 595
Liao, Y.-C., Fernandopulle, M. S., Wang, G., Choi, H., Hao, L., Drerup, C. M., Patel, R., Qamar, S., Nixon-Abell, J., Shen, Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.050 · Cited by 550
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
Mifflin, L., Ofengeim, D., & Yuan, J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0071-y · Cited by 508
Olney, N. T., Spina, S., & Miller, B. L. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.01.008 · Cited by 419
Sellier, C., Campanari, M., Julie Corbier, C., Gaucherot, A., Kolb‐Cheynel, I., Oulad‐Abdelghani, M., Ruffenach, F., Page, A., Ciura, S., Kabashi, E., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201593350 · Cited by 414
Beyond aggregation: Pathological phase transitions in neurodegenerative disease
Mathieu, C., Pappu, R. V., & Taylor, J. P. (2020) · Science · doi:10.1126/science.abb8032 · Cited by 410
Mackenzie, I. R., & Neumann, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13588 · Cited by 409
Moore, A. S., & Holzbaur, E. L. F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523810113 · Cited by 362
Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond
Bingol, B., & Sheng, M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.015 · Cited by 340
Inflammation in ALS/FTD pathogenesis
McCauley, M. E., & Baloh, R. H. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1933-9 · Cited by 341
TBK1: a new player in ALS linking autophagy and neuroinflammation
Oakes, J. A., Davies, M. C., & Collins, M. O. (2017) · Molecular Brain · doi:10.1186/s13041-017-0287-x · Cited by 319
ALS Genes in the Genomic Era and their Implications for FTD
Nguyen, H. P., Broeckhoven, C. V., & van der Zee, J. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.03.001 · Cited by 314
Neuroinflammation in frontotemporal dementia
Bright, F., Werry, E. L., Dobson-Stone, C., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kassiou, M., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0231-z · Cited by 280
Genetics of Amyotrophic Lateral SclerosisPreprint
Ghasemi, M., & Brown, R. H. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024125 · Cited by 292
Autophagy Receptors and Neurodegenerative Diseases
Deng, Z., Purtell, K., Lachance, V., Wold, M. S., Chen, S., & Yue, Z. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.01.001 · Cited by 245
Expanding the ubiquitin code through post‐translational modification
Herhaus, L., & Đikić, I. (2015) · EMBO Reports · doi:10.15252/embr.201540891 · Cited by 240
Deng, Z., Lim, J., Wang, Q., Purtell, K., Wu, S., Palomo, G. M., Tan, H., Manfredi, G., Zhao, Y., Peng, J., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1644076 · Cited by 237
Human TBK1: A Gatekeeper of Neuroinflammation
Ahmad, L., Zhang, S.-Y., Casanova, J.-L., & Sancho-Shimizu, V. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.04.006 · Cited by 208
Gao, F., Almeida, S., & Lopez‐Gonzalez, R. (2017) · The EMBO Journal · doi:10.15252/embj.201797568 · Cited by 227
Motor Neuron Susceptibility in ALS/FTD
Ragagnin, A., Shadfar, S., Vidal, M., Jamali, M. S., & Atkin, J. D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00532 · Cited by 232
Therapeutic targeting of autophagy in neurodegenerative and infectious diseases
Rubinsztein, D. C., Bento, C. F., & Deretic, V. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150956 · Cited by 202
Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress
Höhn, A., Tramutola, A., & Cascella, R. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5497046 · Cited by 208
Autophagy and ALS: mechanistic insights and therapeutic implications
Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J. (2022) · Autophagy · doi:10.1080/15548627.2021.1926656 · Cited by 189
Broce, I., Karch, C. M. M., Wen, N., Fan, C. C., Wang, Y., Tan, C. H., Kouri, N., Ross, O. A., Höglinger, G. U., Müller, U., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002487 · Cited by 195
Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175
Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort
Gijselinck, I., Van Mossevelde, S., van der Zee, J., Sieben, A., Philtjens, S., Heeman, B., Engelborghs, S., Vandenbulcke, M., De Baets, G., Bäumer, V., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002220 · Cited by 174
Mathur, V., Burai, R., Vest, R. T., Bonanno, L. N., Lehallier, B., Zardeneta, M. E., Mistry, K. N., Do, D., Marsh, S. E., Abud, E. M., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.11.032 · Cited by 175
Targeting mitophagy in neurodegenerative diseases
Antico, O., Thompson, P. W., Hertz, N. T., Muqit, M. M. K., & Parton, L. E. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01105-0 · Cited by 187
Genetics of FTLD : overview and what else we can expect from genetic studies
Pottier, C., Ravenscroft, T. A., Sanchez‐Contreras, M., & Rademakers, R. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13622 · Cited by 148
Self-citationFrontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype
Mann, D. M. A., & Snowden, J. S. (2017) · Brain Pathology · doi:10.1111/bpa.12486 · Cited by 163
Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death
Taft, J., Markson, M., Legarda, D., Patel, R., Chan, M., Malle, L., Richardson, A., Gruber, C., Martín-Fernández, M., Mancini, G. M. S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.026 · Cited by 151
The clinical spectrum of sporadic and familial forms of frontotemporal dementia
Woollacott, I., & Rohrer, J. D. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13654 · Cited by 163
MitophAging: Mitophagy in Aging and Disease
Bakula, D., & Scheibye‐Knudsen, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00239 · Cited by 152
Review: neuropathology of non-tau frontotemporal lobar degeneration
Neumann, M., & Mackenzie, I. R. A. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12526 · Cited by 144
Progranulin deficiency causes impairment of autophagy and TDP-43 accumulation
Chang, M. C., Srinivasan, K., Friedman, B. A., Suto, E., Modrusan, Z., Lee, W. P., Kaminker, J. S., Hansen, D. V., & Sheng, M. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160999 · Cited by 141
Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease
Chitramuthu, B. P., Bennett, H. P. J., & Bateman, A. (2017) · Brain · doi:10.1093/brain/awx198 · Cited by 138
Degradation of engulfed mitochondria is rate-limiting in Optineurin-mediated mitophagy in neurons
Evans, C. S., & Holzbaur, E. L. (2020) · eLife · doi:10.7554/elife.50260 · Cited by 137
Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy
Suzuki, N., Nishiyama, A., Warita, H., & Aoki, M. (2022) · Journal of Human Genetics · doi:10.1038/s10038-022-01055-8 · Cited by 148
Béland, L.-C., Markovinovic, A., Jakovac, H., De Marchi, F., Bilic, E., Mazzini, L., Kriz, J., & Munitic, I. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa124 · Cited by 125
Genetic Convergence Brings Clarity to the Enigmatic Red Line in ALS
Cook, C. N., & Petrucelli, L. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.032 · Cited by 126
Frontotemporal Dementia, Where Do We Stand? A Narrative Review
Antonioni, A., Raho, E. M., Lopriore, P., Pace, A. P., Latino, R. R., Assogna, M., Mancuso, M., Gragnaniello, D., Granieri, E., Pugliatti, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411732 · Cited by 133
Significance of optineurin mutations in glaucoma and other diseases
Minegishi, Y., Nakayama, M., Iejima, D., Kawase, K., & Iwata, T. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.08.002 · Cited by 126
Development of disease-modifying drugs for frontotemporal dementia spectrum disorders
Panza, F., Lozupone, M., Seripa, D., Daniele, A., Watling, M., Giannelli, G., & Imbimbo, B. P. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0330-x · Cited by 122
Pottier, C. P., Ren, Y., Perkerson, R. B., Baker, M. C., Jenkins, G. D., van Blitterswijk, M., DeJesus‐Hernandez, M., van Rooij, J., Murray, M. E., Christopher, E. A., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01962-9 · Cited by 117
Self-citationDysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma
Toth, R. P., & Atkin, J. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01017 · Cited by 114
What we know about TMEM106B in neurodegeneration
Nicholson, A. M., & Rademakers, R. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1610-9 · Cited by 110
Self-citationRisk factors and emerging therapies in amyotrophic lateral sclerosis
Nowicka, N., Juranek, J., Juranek, J. K., & Wojtkiewicz, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112616 · Cited by 106
van der Zee, J., Gijselinck, I., Mossevelde, S. V., Perrone, F., Dillen, L., Heeman, B., Bäumer, V., Engelborghs, S., Bleecker, J. D., Baets, J., et al. (2016) · Human Mutation · doi:10.1002/humu.23161 · Cited by 107
TBK1, a central kinase in innate immune sensing of nucleic acids and beyond
Zhou, R., Zhang, Q., & Xu, P. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmaa051 · Cited by 104
Iron and Neurodegeneration: Is Ferritinophagy the Link?
Biasiotto, G., Lorenzo, D. D., Archetti, S., & Zanella, I. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9473-y · Cited by 105
Huang, M., Modeste, E. S., Dammer, E. B., Merino, P., Taylor, G., Duong, D. M., Deng, Q., Holler, C. J., Gearing, M., Dickson, D. W., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01037-x · Cited by 102
Self-citationVan Mossevelde, S., van der Zee, J., Gijselinck, I., Engelborghs, S., Sieben, A., Van Langenhove, T., De Bleecker, J., Baets, J., Vandenbulcke, M., Van Laere, K., et al. (2016) · Brain · doi:10.1093/brain/awv358 · Cited by 98
Increased prevalence of autoimmune disease within C9 and FTD/MND cohorts: Completing the picture
Miller, Z. A., Sturm, V. E., Camsari, G. B., Karydas, A., Yokoyama, J. S., Grinberg, L. T., Boxer, A. L., Rosen, H. J., Rankin, K. P., Gorno-Tempini, M. L., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000301 · Cited by 100
Self-citationCellular Functions of Optineurin in Health and Disease
Slowicka, K., Vereecke, L., & Loo, G. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.07.002 · Cited by 99
Markovinović, A., Cimbro, R., Ljutić, T., Križ, J., Rogelj, B., & Munitić, I. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.04.005 · Cited by 95
Freischmidt, A., Müller, K., Ludolph, A. C., Weishaupt, J. H., & Andersen, P. M. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.3712 · Cited by 95
Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis
Yamashita, S., & Ando, Y. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0036-y · Cited by 105
Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis
Lin, K., Tsai, P., Liao, Y., Chen, W., Tsai, C., Soong, B., & Lee, Y. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.02.008 · Cited by 91
Toward a glutamate hypothesis of frontotemporal dementia
Benussi, A., Alberici, A., Buratti, E., Ghidoni, R., Gardoni, F., Di Luca, M., Padovani, A., & Borroni, B. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00304 · Cited by 90
Genotype–phenotype links in frontotemporal lobar degeneration
Mossevelde, S. V., Engelborghs, S., van der Zee, J., & Broeckhoven, C. V. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0009-8 · Cited by 94
Recent advances in amyotrophic lateral sclerosis
Riva, N., Agosta, F., Lunetta, C., Filippi, M., & Quattrini, A. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8091-6 · Cited by 89
Ling, S., Dastidar, S. G., Tokunaga, S., Ho, W. Y., Lim, K., Ilieva, H. S., Parone, P. A., Tyan, S.-H., Tse, T. M., Chang, J., et al. (2019) · eLife · doi:10.7554/elife.40811 · Cited by 87
Blauwendraat, C., Wilke, C., Simón‐Sánchez, J., Jansen, I. E., Reifschneider, A., Capell, A., Haass, C., Castillo-Lizardo, M., Biskup, S., Maetzler, W., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.102 · Cited by 84
CYLD is a causative gene for frontotemporal dementia – amyotrophic lateral sclerosis
Dobson‐Stone, C., Hallupp, M., Shahheydari, H., Ragagnin, A., Chatterton, Z., Carew‐Jones, F., Shepherd, C. E., Stefen, H., Parić, E., Fath, T., et al. (2020) · Brain · doi:10.1093/brain/awaa039 · Cited by 86
Plasma Inflammatory Cytokines Are Elevated in ALS
Tortelli, R., Zecca, C., Piccininni, M., Benmahamed, S., Dell’Abate, M. T., Barulli, M. R., Capozzo, R., Battista, P., & Logroscino, G. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.552295 · Cited by 90
Heterozygous Tbk1 loss has opposing effects in early and late stages of ALS in mice
Brenner, D., Sieverding, K., Bruno, C., Lüningschrör, P., Buck, E., Mungwa, S., Fischer, L., Brockmann, S. J., Ulmer, J., Bliederhäuser, C., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180729 · Cited by 83
Genetics of Amyotrophic Lateral Sclerosis
Gregory, J. M., Fagegaltier, D., Phatnani, H., & Harms, M. B. (2020) · Current Genetic Medicine Reports · doi:10.1007/s40142-020-00194-8 · Cited by 83
Weil, R., Laplantine, E., Curic, S., & Génin, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01243 · Cited by 83
ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function
de Majo, M., Topp, S. D., Smith, B. N., Nishimura, A. L., Chen, H.-J., Gkazi, S. A., Miller, J. W., Wong, C. H., Vance, C. A., Baas, F., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.015 · Cited by 86
Fenoglio, C., Scarpini, E. A., Serpente, M., & Galimberti, D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170702 · Cited by 89
Synaptic Paths to Neurodegeneration: The Emerging Role of TDP-43 and FUS in Synaptic Functions
Ling, S. (2018) · Neural Plasticity · doi:10.1155/2018/8413496 · Cited by 85
Bonifacino, T., Zerbo, R. A., Balbi, M., Torazza, C., Frumento, G., Fedele, E., Bonanno, G., & Milanese, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212236 · Cited by 82
Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients
Perrone, F., Nguyen, H. P., Mossevelde, S. V., Moisse, M., Sieben, A., Santens, P., Bleecker, J. D., Vandenbulcke, M., Engelborghs, S., Baets, J., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.008 · Cited by 80
Impaired protein degradation in FTLD and related disorders
Götzl, J. K., Lang, C. M., Haass, C., & Capell, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.008 · Cited by 75
TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Bright, F., Chan, G., van Hummel, A., Ittner, L. M., & Ke, Y. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157781 · Cited by 71
Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Kirola, L., Mukherjee, A., & Mutsuddi, M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02934-z · Cited by 79
Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?
Trojsi, F., D’Alvano, G., Bonavita, S., & Tedeschi, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103647 · Cited by 75
Xu, Y., Zhang, S., & Zheng, H. (2018) · Autophagy · doi:10.1080/15548627.2018.1532258 · Cited by 69
Recent Advances in the Genetics of Frontotemporal Dementia
Sirkis, D. W., Geier, E. G., Bonham, L. W., Karch, C. M. M., & Yokoyama, J. S. (2019) · Current Genetic Medicine Reports · doi:10.1007/s40142-019-0160-6 · Cited by 71
Deleon, J., & Miller, B. L. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00027-2 · Cited by 75
Update on recent advances in amyotrophic lateral sclerosis
Riva, N., Domi, T., Pozzi, L., Lunetta, C., Schito, P., Spinelli, E. G., Cabras, S., Matteoni, E., Consonni, M., Bella, E. D., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12435-9 · Cited by 74
Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues
Ferrari, R., Manzoni, C., & Hardy, J. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.02.006 · Cited by 74
Bartolomé, F. B., Esteras, N., Martín‐Requero, Á., Boutoleau‐Bretonnière, C., Vercelletto, M., Gabelle, A., Ber, I. L., Honda, T., Dinkova‐Kostova, A. T., Hardy, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01678-4 · Cited by 66
ALS: Recent Developments from Genetics Studies
Therrien, M., Dion, P. A., & Rouleau, G. A. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0658-1 · Cited by 65
Thalamic atrophy in frontotemporal dementia — Not just a C9orf72 problem
Bocchetta, M., Gordón, E., Cardoso, M. J., Marc Modat, A., Sebastien Ourselin, A., Warren, J. D., & Rohrer, J. D. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.02.019 · Cited by 61
Piscopo, P., Grasso, M., Puopolo, M., D’Acunto, E., Talarico, G., Crestini, A., Gasparini, M., Campopiano, R., Gambardella, S., Castellano, A. E., et al. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180364 · Cited by 58
Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?
Deng, Z., Sheehan, P., Chen, S., & Yue, Z. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0232-6 · Cited by 62
Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum
Shahheydari, H., Ragagnin, A., Walker, A. K., Toth, R. P., Vidal, M., Jagaraj, C. J., Perri, E. R., Konopka, A., Sultana, J. M., & Atkin, J. D. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00119 · Cited by 61
Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia
Ranganathan, R., Haque, S., Coley, K., Shepheard, S. R., Cooper‐Knock, J., & Kirby, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00684 · Cited by 62
Targeting RIPK1 kinase for modulating inflammation in human diseases
Li, W., & Yuan, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1159743 · Cited by 59
Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis
Genin, E. C., Abou-Ali, M., & Paquis‐Flucklinger, V. (2023) · Genes · doi:10.3390/genes14111981 · Cited by 64
Dzamko, N. L. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-49969-7_7 · Cited by 62
The role of DNA damage response in amyotrophic lateral sclerosis
Sun, Y., Curle, A. J., Haider, A. M., & Balmus, G. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200002 · Cited by 58
Guo, W., Vandoorne, T., Steyaert, J., Staats, K. A., & Bosch, L. V. D. (2020) · Brain · doi:10.1093/brain/awaa022 · Cited by 58
Clinico-genetic findings in 509 frontotemporal dementia patients
Wagner, M., Lorenz, G., Volk, A. E., Brunet, T., Edbauer, D., Berutti, R., Zhao, C., Anderl‐Straub, S., Bertram, L., Danek, A., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01271-2 · Cited by 59
Mendelian neurodegenerative disease genes involved in autophagy
Stamatakou, E., Wróbel, L., Hill, S. M., Puri, C., Son, S. M., Fujimaki, M., Zhu, Y., Siddiqi, F. H., Fernandez-Estévez, M., Manni, M. M., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-0158-y · Cited by 52
Sahu, R., Upadhayay, S., & Mehan, S. (2021) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2021.151179 · Cited by 57
Metadata
- Authors
- Pottier, C., Bieniek, K. F., Finch, N., van de Vorst, M., Baker, M., Perkersen, R., Brown, P., Ravenscroft, T., van Blitterswijk, M., Nicholson, A. M., DeTure, M., Knopman, D. S., Josephs, K. A., Parisi, J. E., Petersen, R. C., Boylan, K. B., Boeve, B. F., Graff-Radford, N. R., Veltman, J. A., Gilissen, C., Murray, M. E., Dickson, D. W., & Rademakers, R.
- Affiliations
- Mayo Clinic (US)
- Radboud University Nijmegen (NL)
- Corresponding author
- Rademakers, Rosa
- ORCID
- Venue
- Acta Neuropathologica
- Published
- 2015-05-06
- Volume
- 130
- Issue
- 1
- Pages
- 77-92
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC4470809
- OpenAlex
- W239648239
- Cited by
- 312
- References
- 63
- Citations by year
- 2026: 8 · 2025: 21 · 2024: 14 · 2023: 18 · 2022: 16 · 2021: 32 · 2020: 48 · 2019: 32 · 2018: 38 · 2017: 34 · 2016: 37 · 2015: 14
- FWCI
- 28.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- PubMed Central (acceptedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- National Institutes of Health (R01 AG037491, R01 NS076471, R01 NS080882, R01 AG026251, P50 AG016574, U01 AG006786)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- frontotemporal dementia, optineurin, TBK1, loss-of-function mutations, compound heterozygosity, copy number variation, single nucleotide variants, oligogenic inheritance, amyotrophic lateral sclerosis
- MeSH terms
- Aged, Aged, 80 and over, Brain, Female, Humans, Immunohistochemistry, Male, Mutation, RNA, Messenger, Blotting, Western, Cohort Studies, Gene Expression, Motor Neuron Disease, Protein Serine-Threonine Kinases, Sequence Analysis, DNA, Cell Cycle Proteins, Membrane Transport Proteins, Transcription Factor TFIIIA, DNA Copy Number Variations, Frontotemporal Lobar Degeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
